devhealthylife1@gmail.com

Meta slated to reported second-quarter earnings after the bell

Meta slated to reported second-quarter earnings after the bell

Mark Zuckerberg, CEO of Meta Platforms. David Paul Morris | Bloomberg | Getty Images Meta is set to report its second-quarter earnings on Wednesday, with analysts eyeing any changes to the company’s costs and related guidance amid CEO Mark Zuckerberg’s recent artificial intelligence hiring blitz. Here’s what analysts polled by LSEG are expecting: Earnings per…

Read More
Stocks making the biggest moves midday: HOG, WING, SRPT

Stocks making the biggest moves midday: HOG, WING, SRPT

Check out the companies making the biggest moves midday: Harley-Davidson — The motorcycle manufacturer rallied 16% after the company announced a partnership between its financing arm and private asset manager KKR as well as Pimco. “This partnership transforms [Harley-Davidson Financial Services] into a capital-light financing business through the sale of existing and future retail loans…

Read More
Zuckerberg shares AI superintelligence vision after spending spree

Zuckerberg shares AI superintelligence vision after spending spree

Meta CEO Mark Zuckerberg published a letter outlining his vision for “personal superintelligence” Wednesday, giving investors a glimpse into his artificial intelligence strategy ahead of Meta’s second-quarter earnings report. The company has shelled out billions of dollars hiring top AI researchers and engineers in recent weeks, and Wall Street will be listening for what Zuckerberg…

Read More
AstraZeneca proposes U.S. drug price cuts to Trump

AstraZeneca proposes U.S. drug price cuts to Trump

The office building of international biopharmaceutical company AstraZeneca. Cfoto | Future Publishing | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. President Donald Trump has been pressuring pharmaceutical companies to lower U.S. drug…

Read More